Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Revenue

Bioray Biotech had revenue of 98.58M TWD in the half year ending June 30, 2026, with 14.90% growth. This brings the company's total for the last twelve months to 207.17M, down -9.95% year-over-year. In the year 2025, Bioray Biotech had annual revenue of 222.73M with 10.42% growth. That makes Bioray Biotech the 39,140th largest company in the world by revenue and 2,038th in Taiwan.

• Revenue (ttm): 207.17M
• Revenue Growth: -9.95%
• P/S Ratio: 2.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 548.81M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	222.73M	21.01M	10.42%
Dec 31, 2024	201.71M	9.88M	5.15%
Dec 31, 2023	191.83M	1.23M	0.65%
Dec 31, 2022	190.60M	42.58M	28.77%
Dec 31, 2021	148.02M	-8.28M	-5.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error